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Zusammenfassung
Multikriterielle Optimierung in der inversen Strahlentherapieplanung
Die Entwicklung der intensita¨tsmodulierten Strahlentherapie (IMRT) hat die Mo¨glichkeiten
zur Gestaltung der Dosisverteilung stark erweitert. Aber auch mit IMRT ist aufgrund physika-
lischer Begrenzungen eine gewisse Dosis in Risikoorganen unvermeidbar, so dass in der Be-
strahlungsplanung oft ein Kompromiss zwischen einzelnen Plankriterien geschlossen werden
muss. Diese Arbeit stellt ein neues Optimierungskonzept vor, das diesem Problemcharakter
angepasst ist. Es basiert auf der Tatsache, dass es nicht einen einzigen optimalen Plan gibt,
sondern viele sog. Pareto optimale Pla¨ne, die in keinem Kriterium zu verbessern sind, ohne
ein anderes zu verschlechtern. Es wird eine Datenbank mit allen Pareto optimalen Pla¨nen
erstellt und dem Planer die endgu¨ltige Entscheidung u¨ber den klinisch sinnvollsten Kompro-
miss u¨berlassen. Wegen des erho¨hten Rechenaufwandes wurde zuna¨chst die Dosisberechnung
des vorhandenen Planungssystems durch statistisches Ausdu¨nnen der Berechnungsmatrizen
um den Faktor drei beschleunigt. Zur Beschreibung eines Plans wird ein Vektor mit den
’equivalent uniform doses’ (EUDs) der einzelnen Strukturen verwendet. Dazu wurden zwei
Modelle der EUD analysiert, das sog. ’max & mean’ und das ’generalized mean’ Modell.
Weiterhin wurde ein Verfahren entwickelt, das das ’generalized mean’ Modell der EUD in
die Optimierung eines Plans einbezieht. Zum Abschluss der Arbeit wurde fu¨r einen klin-
ischen Beispielfall mit 1 Zielvolumen und 2 Risikoorganen die Datenbank aller Pareto op-
timalen Lo¨sungen generiert und visualisiert. Der Planer kann damit auf einen Blick die
Abha¨ngigkeiten der einzelnen Planstrukturen erkennen und sich fu¨r den klinisch besten Plan
entscheiden.
Abstract
Multicriteria Optimization in Inverse Radiotherapy Planning
The development of intensity-modulated radiotherapy (IMRT) has greatly enhanced the pos-
sibilities of shaping the dose distribution. However, because of physical limitations, even
with IMRT a certain dose to organs at risk is unavoidable, so in treatment planning often
a compromise between different plan criteria has to be found. This thesis presents a new
optimization concept that is dedicated to this type of problem. It is based on the fact that
there is no single optimal plan, but many so-called Pareto optimal plans, which cannot be im-
proved in one criterion without worsening another. A database with all Pareto optimal plans
is generated and the decision which compromise is clinically the best is left to the planner.
Because of the higher calculation complexity, the dose calculation of the existing planning
system was accelerated by a factor of three through statistical sampling of the calculation
matrices. To describe a plan, a vector containing the ’equivalent uniform doses’ (EUDs) of
each structure is used. Therefore two EUD models were analyzed, the ’max & mean’ and
the ’generalized mean’ model. An algorithm was developed to include the ’generalized mean’
model in the plan optimization. At the end of the thesis, the database containing all Pareto
optimal solutions of a clinical test case with 1 target volume and 2 organs at risk was gener-
ated and visualized. The planner can see at first sight the dependencies of the different plan
elements and can decide which plan is clinically the best.
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Chapter 1
Introduction
Radiotherapy is, after surgery, the second most important treatment option
against cancer. Every second cancer patient is treated with radiation, as the
only form of treatment or in combination with surgery and chemotherapy. The
goal of radiotherapy is to achieve tumor control without causing complications.
Therefore a high dose of radiation must be delivered to the tumor and, at the
same time, the dose to the surrounding normal tissue must be as low as possible.
A main research topic in radiotherapy is focussed on realizing a high degree
of dose conformality, which is the restriction of the high dose area to the tumor
target volume. During the last decade, a major improvement in this field was
achieved by the development of intensity-modulated radiotherapy (IMRT). As
the name implies, in IMRT the intensities of the incident beams can be varied
and are no longer uniform over the whole aperture. Using this technique, complex
shaped dose distributions can be realized. This allows better sparing of organs at
risks and higher doses to the target volume, especially in cases where the target
volume is concave and directly adjacent to organs at risk. Nevertheless, because of
physical limitations, even IMRT cannot deliver the ideal dose distribution, which
is 100% in the target volume and 0% everywhere else. While IMRT does allow
to achieve somewhat steeper dose gradient between normal tissue and the target
volume, especially for irregularly shaped targets, the steepness of the gradients is
still physically limited; the 20% to 80% penumbra is at least about 6 mm wide.
As a consequence of this, if the target is directly abutting to a critical structure,
the minimum target dose equals the maximal dose in the critical structure. In a
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more general sense, the goals of delivering a high dose to the target and a small
dose to the critical structures contradict each other. A realistic objective can
only be to find a suitable compromise between target coverage and normal tissue
sparing. It is part of the treatment planning to find the compromise which is
clinically the best for the individual patient.
In conventional radiotherapy forward planning, the planner usually defines
the treatment setup (e.g. number and directions of beams, wedges, apertures),
lets the computer calculate the resulting dose and changes the setup until the
plan is acceptable. This is no longer possible in IMRT because of the many de-
grees of freedom - the intensities of up to several hundred beam elements have
to be adjusted independently. Therefore the inverse planning scheme is used:
The planner prescribes what dose inside the target volume is desired and what
doses in critical structures can be tolerated, and the computer tries to find the
treatment plan which is optimal with respect to the prescriptions. Most current
inverse planning systems accomplish this task through an iterative optimization
process that grades the plans by a one-dimensional objective function, so the
optimal plan is the one with the best objective function value. It is quite obvious
that characterizing something as complex as a treatment plan by a single number
is extremely difficult. Often the resulting plan is clinically not satisfactory, and
repeated optimization runs with different constraint settings may become neces-
sary. This trial and error process is time consuming and holds the risk of clinical
sub-optimal treatment plans.
This thesis is focussed on a different optimization strategy, in which IMRT
optimization is tackled using a so-called multicriteria approach. As said, there are
several criteria in a treatment plan which cannot be optimal all at the same time.
This makes the plan optimization problem inherently multicriterial: There is no
single best solution - instead, there are many best compromises, also called Pareto
optimal or efficient. A solution is Pareto optimal if it cannot be improved in one
criterion without worsening at least one of the others. As a measure for the dose
inside each structure, the equivalent uniform dose (EUD) is used. It is defined
as the homogenous dose with the same clinical effect as the given inhomogenous
dose distribution. This is potentially of higher clinical relevance than other dose
distribution parameters like the minimum and maximum physical energy dose.
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In the multicriteria concept, a treatment plan is no longer represented by an
abstract scalar objective function value, but rather as a vector containing the
EUD values of each structure.
The goal of multicriteria optimization in treatment planning is to generate a
database containing all Pareto optimal solutions that might be of clinical interest,
and leave the decision which solution is eventually the best for the patient to the
treatment planner. The dose distributions in the relevant critical structures and
in the target volume are controlled separately and interactively. An intuitive
graphical interface assists the planner in browsing the database.
The thesis is structured as follows. Chapter 2 discusses the current state
of the art in inverse planning and the concept of multicriteria optimization in
more detail. Chapter 3 addresses the acceleration of dose calculation inside the
optimization loop. Chapter 4 introduces the equivalent uniform dose, compares
two different EUD models and fits the models to clinical data. Chapter 5 describes
how the EUD is implemented as an optimization constraint. In chapter 6 the
multicriteria concept is used to optimize a simple clinical case. All algorithms
presented so far are utilized, and some other techniques that will be necessary for
more complex cases are introduced as well. Chapter 7 summarizes the presented
material. It also includes an outlook for the future work on this project.
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Chapter 2
The multicriteria approach in
intensity-modulated
radiotherapy - A new
optimization paradigm
Intensity-modulated radiotherapy (IMRT) has a much greater potential to shape
dose distributions than conventional radiotherapy with uniform beams (IMRT
Collaborative Working Group 2001). This capability has been used to tailor
the dose distribution to the tumor target volume in conformal radiotherapy. In
general IMRT allows one to achieve a better dose conformality, especially for ir-
regularly shaped concave target volumes. The improved physical characteristics
of IMRT can lead to improved clinical results, as was suggested in recent clinical
studies (Zelefsky et al. 2000). Although IMRT is already in clinical use at several
hospitals in Europe and many in the USA, there is a lot of potential and need
for further improvements. The first hurdle is the initial implementation and the
commissioning of the IMRT system in a clinical environment. Vendors advertise
turn-key IMRT solutions but the reality may look different. Often the problem is
to link the different elements of the IMRT planning and delivery chain. Current
developments aim at more streamlined and integrated solutions. Another impor-
tant point is that - because IMRT is more complex - it requires an elaborate, if
possible patient-specific verification. More efficient tools are needed to make this
5
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process less labor-intensive and time-consuming. Most vendors now offer IMRT-
ready multileaf collimators (MLC) that are able to deliver IMRT automatically,
without user intervention. The delivery time varies between the vendors but is
generally clinically acceptable. Other developments aim at improving the plan-
ning of IMRT. This involves at the far end the translation of calculated intensity
maps into sequences of MLC positions. On the other hand there is the calcu-
lation of the intensity maps itself. Some recent approaches also try to optimize
the sequence of MLC shapes directly, without going through the intermediate
step of the intensity maps. In most systems IMRT planning is considered as an
optimization problem. The goal is to find the parameters–intensity maps, some-
times also beam orientations (e.g. Pugachev 2001), energy, etc.–that yield the
best possible treatment plan under consideration of various clinical, technical,
and physical constraints. A huge number of current research activities is related
to this problem.
This thesis is focussed on the optimization problem as well. In this chap-
ter, the current status of existing systems and a new multicriteria approach (cf.
Bortfeld et al. 2002) is presented.
2.1 Current optimization strategies
In current IMRT planning systems, following techniques exist to control the op-
timization result:
1. Weight factors
One way is to combine objectives or costlets for the different critical struc-
tures (FR) and the target volume (FT ) using weight factors w (also called
penalties or importance factors). Mathematically, an objective function is
defined that is of the form F = wTFT +wR1FR1+wR2FR2+ . . .+wKFK . By
using a large value for wT , more emphasis is placed on the target dose, and
vice versa. Figure 2.1 shows dose-volume histograms of optimized IMRT
plans for the treatment of a head and neck tumor. Two extreme values
of the weight factor were used. A problem with this approach is that the
weight factors have no clinical meaning. Suitable weight factors have to be
determined by trial and error, which may be quite time consuming.
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Figure 2.1: IMRT planning for a head and neck tumor using optimization with
weight factors. Plan 1 is the optimization result with weight factors 1000 for
target and 10 for spinal cord and brainstem, whereas plan 2 is the result with
weightings 10 for target and 1000 for spinal cord and brainstem. As can be
seen from this figure, the artificial weighting factors can radically change the
optimization result. The equivalent uniform dose (EUD, see chapter 4) for the
target volume changes from 57.8 Gy for plan 1 to 3.2 Gy for plan 2.
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Figure 2.2: Same case as in Figure 2.1. Here constrained optimization was used.
The dose constraints for the spinal cord and the brainstem were set to 37 Gy.
According to these constraints, plan 1 is mathematically equivalent to Plan 2.
However, plan 2 is clearly better in terms of sparing the brainstem.
2. Constraints
Another approach, which is also used in commercial planning systems, uses
constraints on the maximum dose in the critical structures or the minimum
dose in the target. Here the potential problem is that there is no reward for
reducing the dose in the critical structures below the tolerance. Figure 2.2
shows an example with two critical structures, one of which is dose limiting
for the target volume, but the other one is not. In fact, it is easily possible
to reduce the dose in the brainstem without compromising the dose in any
of the other structures. Hence, although both plans in figure are clinically
acceptable, plan 2 is clearly better.
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A problem with both of the above approaches (weighting and constraining) is that
in general the sensitivity of the optimization result to changes is unknown. That
means, it is unclear how dependent the dose in one structure is on the constraints
in other structures, e. g. the planner does not know how much dose in a critical
structure could be saved if he is willing to accept a certain target dose reduction.
After the first optimization run, the system will come up with a result that
is mathematically optimal with respect to the given objective function and con-
straints. However, this does not mean that the plan is also clinically acceptable.
The reason is that the optimization criteria used in the optimization may not
be clinically relevant. If a physician looks at the plan he or she usually wants
to change the plan here and there. Now the treatment planner has the task to
perform the desired modification with the available ”knobs”, that is with dose
constraints, weight factors, and so on. Often these knobs are not well suited to
do the modification. Several runs are generally required to come up with a suit-
able solution. This trial and error can take a lot of time. This is why optimized
”inverse” planning is not a push-button solution.
2.2 The new optimization paradigm
To solve the above-mentioned drawbacks and problems in IMRT planning, a new
optimization concept was developed in collaboration between the German Can-
cer Research Center (DKFZ) in Heidelberg/Germany, the Fraunhofer Institute
for Industrial Mathematics (ITWM) in Kaiserslautern/Germany, and the Mas-
sachusetts General Hospital (MGH) in Boston/USA. Instead of defining a scalar
objective function as a measure of the quality of the treatment plan, the new
approach is inherently multicriterial. The multicriteria optimization concept was
already used in planning of brachytherapy (Lahanas et al. 1999, Milickovic et
al. 2002), but up to now no solution existed for planning of external radiother-
apy. The dose distribution in each structure (critical structures and target) is
characterized by its own, separate parameter. There are several options of what
this parameter can be. One option would be the sum of quadratic differences
to a specified dose constraint, which is a common criterion in existing planning
systems. In the following, a probably clinically more relevant parameter will be
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used, the equivalent uniform dose (EUD). The EUD is defined as the uniform
dose that leads to the same clinical effect as the actual non-uniform dose in that
organ. Using EUD, volume effects (most noticable in parallel organized organs
like the lung) are automatically considered in the optimization process. The
whole plan is characterized by a vector containing the EUDs of all structures,
−→
F = (FT , FR1, FR2, . . . , FK). What we seek is an optimal compromise between
the target and the critical structures. Now, there is an infinite number of feasible
combinations of those parameter sets. To make the search tractable, we look at
so-called efficient (Pareto optimal) solutions only. These are defined as solutions
in which an improvement in one organ will always lead to a worse result in at
least one of the other organs.
The advantages of this concept are threefold:
1. Artificial weight factors, which have no clinical meaning, are avoided. The
whole concept is based on dose-like values, which are amenable to a clinical
interpretation.
2. Unnecessarily high doses in some of the critical structures, which can occur
in constrained optimization (see above), are avoided by definition of the
efficient (Pareto optimal) solution.
3. Plan tuning can be done interactively using ”knobs” that have a clinical
meaning. It is easy to do a sensitivity analysis and determine the depen-
dency of, say, the target EUD on any of the critical structure EUDs.
The optimization procedure is split into two parts: First, the system automati-
cally generates a database of Pareto optimal plans. Once started, this step does
not require user interaction and can be performed over night. The second part is
the interactive planning session in which the planner explores the database and
finally selects the plan that will be used for treatment.
2.2.1 Database generation
Goal of this stage is generating a database containing a representative system
of all Pareto optimal plans that are of clinical interest. A graphical illustration
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of the problem is shown in Figure 2.3. It is not practible to store all plans
that are Pareto optimal: E.g., all intensities set to zero will lead to zero dose
in every voxel, which is a Pareto optimal plan because due to scatter any dose
improvement in the target will worsen the dose in critical structures. But a plan
with no dose to the target is clearly not of clinical interest. Another extreme would
be a plan with intolerable high doses to vital organs at risk like the brainstem.
So, only a subset of all Pareto optimal plans is of clinical interest. Even with
restriction to this subset, there is an infinite number of Pareto optimal plans
left because the dose distributions continuously change with the intensities and
the difference between two Pareto optimal plans can become infinitesimal small.
If the differences between two plans are not visible to the human eye e.g. by
means of their isodoses or dose volume histograms, it would not make sense
to store both of these plans in the database. Instead, all plans in the database
should be significantly different (resolution criterion) and at the same time nearly
equidistantly cover the whole area of clinical interest (homogeneity criterion).
In practice, the procedure goes as follows: Initially the treatment planner
roughly specifies the desired dose in the target volume and the dose he is willing
to tolerate inside the organs at risk. This will lead to a first treatment plan,
which is stored as the starting solution. Subsequently the planning system will
produce all other plans and build the database according to the criteria given
above. Every plan will be normalized to the desired dose in the target volume,
and for each plan following information is stored in the database:
• F-vector containing the EUD values of all structures
• treatment setup (e.g. number and directions of beams, intensity maps)
• data for dose visualisation (e.g. isodose vectors, dose volume histogram, 3D
dose cube)
• relationship to the neighboring plans
The plans are calculated and the database is filled over night. One can see that
in this concept the definition of the initial constraints is not critical. It is only
used to generate a starting solution that lies somewhere in the area of clinical
interest.
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Figure 2.3: Only a subset of all Pareto optimal solutions is of clinical interest.
It is part of the multicriteria optimization concept to generate a database with
representative solutions covering the area of clinical interest.
This thesis is mainly focussed on the database generation part of the mul-
ticriteria optimization concept. As development basis and calculation platform,
an experimental inverse planning system (Nill 2001) based on KonRad (Preiser
et al. 1997) was used. The algorithms which are presented in the next chapters
were all integrated into and tested with this system. This way there was no need
for re-programming basic functionalities like CT data import, beam configuration
setup and visualization capabilities.
2.2.2 Interactive planning session
After the database has been created, the treatment planner can browse through
it interactively. Figure 2.4 shows the graphical user interface of a search tool that
was developed by mathematicians from the Fraunhofer Institute for Industrial
Mathematics in Kaiserslautern. The screen is divided into four main windows:
The information window shows basic information like patient name and irradia-
tion device. The current plan is shown in the isodose and dose volume histogram
windows. The central part of the program is the navigation window. Here, every
structure of the plan is represented with its own axis used for the EUD values.
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In the example of Fig. 2.4 there are one target and three organs at risk. All
EUD values that can be reached through the database are defining the planning
horizon, shown in the navigation window as the area with gray background. The
planner sees right from the start which EUD value in each organ can reached.
The current plan is highlighted in the navigation window by a polyhedron (purple
line fig. 2.4) defined by the EUD value of each structure. If one or more aspects of
the plan are not desirable (e.g., the EUD in one critical structure is too high), the
planner can immediately go to another plan which satisfy that specific criterion.
This is done by clicking and dragging the EUD marker of the particular organ in
the desired direction. Instantaneously, the system finds the corresponding plan
in its database and updates the information for the other structures and in the
isodose and dose volume histogram windows. This gives the planner immediate
feedback about the sensitivity of the problem. To give more control over the plan
selection, it is possible to ”lock” an organ by clicking on the box at the end of
the respective EUD bar. If an organ is ”locked”, all treatment plans with a worse
EUD than the actual one are excluded from the further database exploration.
The reduced planning horizon is visualized in the navigation window by a differ-
ent shade of the gray background (see also fig. 2.4, where the organ at risk “h3”
is locked).
As mentioned in the database generation section, all plans in the database
have the same target EUD value. This is the reason why there is no “lock” box
for the target bar. But nevertheless the target EUD can be changed. This is done
in a different way than for organs at risk: By dragging the target EUD arrow,
all plans in the database are re-scaled to the desired target EUD. All other plan
components are scaled by the same factor, so the range of EUD values that can be
reached in the organs at risk will change as well. The advantages of this concept
are that there is no restriction for the target dose, and that for every target dose
the complete database of Pareto optimal plans is accessible.
It is not necessary to look at each and every plan stored in the database.
Instead, the interface is designed to guide the planner to the best plan for the
patient in as few steps as possible.
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Figure 2.4: Prototype version of the interactive search tool developed at the
ITWM in Kaiserslautern. In the navigation window, every structure is repre-
sented by a bar indicating the range of feasible EUD values. The dose distribu-
tion of the actual treatment plan is also visualized as isodoses and as dose volume
histogram.
Chapter 3
Acceleration of dose calculation
through importance sampling
In inverse planning for intensity-modulated radiotherapy, the dose calculation
is a crucial element limiting both the maximum achievable plan quality and the
speed of the optimization process. One way to integrate accurate dose calculation
algorithms into inverse planning (implemented in the inverse planning program
used for this thesis) is to precalculate the dose contribution of each beam element
to each voxel for unit fluence. These precalculated values are stored in a big dose
calculation matrix. Then the dose calculation during the iterative optimization
process consists merely of matrix look-up and multiplication with the actual flu-
ence values. However, because the dose calculation matrix can become very large,
this ansatz requires a lot of computer memory and is still very time-consuming,
making it not practical for clinical routine without further modifications.
The time problem becomes even more serious when in a multicriteria setting
many plans have to be created. As a prerequisite for the multicriteria optimization
project, it was therefore indispensable to accelerate the dose calulation algorithm
of the inverse planning system.
This chapter presents a new method to significantly reduce the number of
entries in the dose calculation matrix. The method utilizes the fact that a photon
pencil beam has a rapid radial dose fall-off, and has very small dose values for the
most part. In this low-dose part of the pencil beam, the dose contribution to a
voxel is only integrated into the dose calculation matrix with a certain probability.
15
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Normalization with the reciprocal of this probability preserves the total energy,
even though many matrix elements are omitted. Three probability distributions
are tested to find the most accurate one for a given memory size. The sampling
method is compared with the use of a fully filled matrix and with the well-known
method of just cutting off the pencil beam at a certain lateral distance. A clinical
example of a head and neck case is presented. It turns out that a sampled dose
calculation matrix with only 1/3 of the entries of the fully filled matrix does not
sacrifice the quality of the resulting plans, whereby the cut-off method results in
a sub-optimal treatment plan.
3.1 Introduction
Various inverse treatment planning programs are now commercially available.
Common to all is that they use simplified dose calculation algorithms in the
optimization of the treatment plans. Therefore, in most cases an independent,
accurate dose calculation is recommended as the final step in inverse planning in
order to verify the dose distribution. Although this is not a big burden, it makes
the inverse planning process less efficient than it could be. More importantly, in
geometrically or physically complex cases, e.g. with severe tissue inhomogeneities,
the dose distribution calculated with inverse planning can deviate significantly
from the more accurately calculated distribution, and could therefore be sub-
optimal.
An obvious approach to overcoming this problem is the use of more accurate
dose calculation algorithms within the inverse planning program. However, be-
cause inverse planning is iterative and requires the dose to be calculated in the
order of 100 or more times, this is in conflict with the requirement that inverse
planning should be reasonably fast, and ideally interactive. In a recent publica-
tion it was reported that using a hybrid approach combining one simplified and
one more accurate dose calculation, the number of accurate calculations could be
significantly reduced down to 5-10 (Siebers et al. 2001). Nevertheless, this still
can be quite time consuming.
The inverse planning system that was used as calculation platform for this
thesis uses another method. It calculates the dose distribution only once for
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each pencil beam before the optimization, store it in a large matrix, and access
this pre-calculated dose in each iteration step of the inverse planning procedure.
The system knows the dose in each voxel, and it knows the contributions from
each bixel to this dose. In addition to the accurate dose calculation, this has the
advantage that the lateral scatter can be taken into account also in the projection
step of the optimization where the bixel intensities are updated.
Fortunately, the increased RAM storage capacity of modern computers has
almost made it possible to implement this approach practically. Unfortunately,
we are not quite there yet. Consider a realistic case in which there are 500 beam
elements (bixels) in each of 9 treatment fields, and the number of volume elements
(voxels) for which the dose is to be optimized is 200,000. If each dose value is
stored as a 2 byte integer value in combination with a 4 byte index to the voxel,
the required RAM storage space is in the order of 4-5 Gbyte, which is still too
much for most modern computers. Moreover, the calculation of all these matrix
entries (even it is done only once) and their subsequent access in the optimization
loop would be time consuming.
A simple way to reduce the required storage space and increase the calculation
speed is to calculate and store dose values only for the critical structures and the
target volume. This alone leads to a sevenfold speed increase, depending on the
specific case. For a fast calculation of specific treatment plan parameters (e.g.,
the DVH or TCP/NTCP-values) it was proposed to calculate only a small subset
of the dose points inside a region of interest (Niemierko and Goitein 1990, Lu
and Chin 1993). A speedup of the complete dose calculation is possible with the
help of certain approximations. The crude method is to cut the pencil beams at
a certain radial distance, say 15 mm, i.e., all elements beyond 15 mm radius are
ignored (Cho and Phillips 2001). However, this approach leads to obvious errors
in the scatter dose distribution and in the output factor.
The goal of this chapter (see also Thieke et al. 2002a) is to develop compact
storage and access techniques for pencil beams, particularly but not solely in
inverse treatment planning. The principal idea is to sample the pencil beam dose
distribution according to the pencil beam value. The central part of the pencil
beam is fully sampled, while outer regions are sampled with a certain probability
distribution, i.e., not every element is stored. A weighting is applied to conserve
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the imparted energy, even when a certain percentage of pencil beam elements
is omitted. Because in general many pencil beams contribute to each voxel, the
result is a correctly predicted dose distribution with a small statistical fluctuation.
The approach is similar to Monte Carlo integration techniques.
3.2 Methods
Because dose is defined as the absorbed energy, the dose to a volume element
(voxel) in the patient can be written as the linear superposition of dose contri-
butions from each beam. This concept can be extended to IMRT, where the
contribution from each beam element (bixel) has to be considered. If the IMRT
is delivered with a multileaf collimator (MLC), non-linearities can be introduced
by certain leaf designs, such as the tongue and groove effect (Mohan 1995). How-
ever, these effects are minor and are disregarded here. We therefore write the
dose di at voxel i in the form
di =
∑
j
Dijwj, (3.1)
where wj is the weight (proportional to fluence and intensity) of the j-th
bixel (macro pencil beam). The dose calculation matrix D is a pre-calculated
matrix where element Dij is the fractional dose contribution from a normalized
pencil beam j to the voxel i. Typical resolutions are (1 cm)2 per bixel and (2.5
mm)3 per dose voxel, resulting in an order of magnitude of 109 Dij elements for a
typical clinical case. If higher resolutions are required, the number ofDij elements
increases correspondingly. As mentioned in the introduction, a computer cannot
handle this amount of data easily, even if the latest generation is used.
Let us consider a particular macro pencil beam with index j. We should recall
that a pencil beam has a rapid lateral dose fall-off, i.e., the value of Dij strongly
depends on the radial distance r between the central ray of the pencil beam j
and the voxel i. In fig. 3.1 the lateral dose distribution of a 15 MV (1 cm)2 pencil
beam in water is shown at a depth of 10 cm (solid line).
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Figure 3.1: Dose distribution of a (1 cm)2 15 MV photon pencil beam in water
at a depth z=10 cm.
The dose was calculated by a clinically approved pencil beam algorithm de-
veloped at the German Cancer Research Center by Bortfeld et al. (1993). At a
radial distance r = 25 mm the dose has already dropped to less than 1% of the
maximum value at the central ray. Therefore a simple approach for reducing the
size of the matrix D is to omit all Dij elements above a certain radial distance
or below a certain dose value. However, the error introduced into the dose calcu-
lation by using such a reduced matrix is quite noticeable. This can be seen from
the dashed curve in fig. 3.1, which represents the integral of the pencil beam
up to the radial distance r and which can be considered as the output factor. If
the lateral cut off distance is set to 25 mm, the calculated output factor does not
increase for fields with radii larger than 25 mm. This can lead to errors of 16% for
large fields. To keep the error of the dose calculation below 4%, the pencil beam
must be taken into account up to a lateral distance of 82 mm. Wherever the term
“fully filled Dij matrix” is used in the following, it refers to a dose calculation
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matrix where all elements up to a radial distance of 82 mm from the voxel i to
the central ray of the bixel j are accounted for.
In this chapter a new approach is proposed for omitting a large percentage
of the Dij elements without causing the problems associated with the cut-off
approach. The idea is that, starting from a radial distance r0, we consider Dij
elements only with a certain probability Pij. With a probability of 1 − Pij the
element Dij will be disregarded. Elements within a circle of radius r0 are consid-
ered with a probability of Pij = 1. To preserve the total energy, the element Dij
is multiplied by P−1ij , i.e., instead of Dij we use
D˜ij = [Dij]Pij · P−1ij . (3.2)
The subscript Pij indicates that the element Dij is integrated into D˜ij with the
probability Pij.This approach ensures that even outer regions of the pencil beams
are represented, and the energy delivered by the beam is completely enclosed in
the Dij matrix. The tradeoff for reducing the number of matrix elements this way
is random noise in the dose distribution, but it can be expected that the noise is
not very high due to two reasons: First, the sampling is only done in low-dose
regions, and second, usually for every voxel many pencil beams contribute dose,
so many noise patterns are superimposed and the resulting noise level is lower
than for one single pencil beam. For this to work effectively the random sampling
has to be performed individually for each pencil beam; a fixed sampling pattern
would introduce artefacts in the resulting dose distribution.
Both the number of the resulting D˜ij elements and the noise level depend
on the radius r0 and the probability distribution used for the sampling outside
r0. Three types of probability distributions have been tested: constant sampling
probability, linearly decreasing probability beginning with P = 1 at r = r0, and a
sampling probability that is proportional to the original pencil beam dose value
at the particular voxel (also beginning with P = 1 at r = r0). The latter leads to
a constant value of D˜ij at radii larger than r0. All three modes of sampling are
graphically compared in fig. 3.2.
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Figure 3.2: Sampling of the (1 cm)2 pencil beam with (a) constant, (b) linear
decreasing, and (c) dose proportional sampling probability. The voxel resolution
was set to 2 mm, the sampling starts at r = 25 mm. The probability distribution
is shown as a dashed line. For each probability distribution, an exemplary set of
nine sampling values is shown as dashed bars.
22 CHAPTER 3. ACCELERATION OF DOSE CALCULATION
The correlation between the number of D˜ij elements and the accuracy of dose
calculation was investigated for all three sampling modes, as well as for the cutoff
technique. Accuracy means the degree of agreement between the calculations
with the reduced matrices and those with the full dose calculation matrix. As
stated above, nonlinear effects of the beam delivery device like the tongue and
groove effect are disregarded in the Dij approach in general. To find the optimal
sampling parameters for clinical use, treatment plans (including beam profiles)
were compared resulting from inverse planning with fully filled and reduced ma-
trices. As a reference standard for calculating the accuracy of each method the
approved pencil beam algorithm mentioned above was used. The existing inverse
planning system (Nill 2001) was enhanced by the option of using the pencil beam
sampling technique. In both cases—full and reduced matrices—the optimized
fluences were transferred to the independent, approved dose algorithm (Bortfeld
et al. 1993) and the dose was recalculated. In the case of the cutoff technique, the
dose (and the intensity) was scaled to the correct mean target dose because, for
reasons mentioned above, this techniques did not yield the correct absolute dose
level. Several clinical cases (a head and neck tumor shown in fig. 3.3, a prostate
cancer case and a skull base tumor) have been tested, and various settings for
r0 (20, 25 and 30 mm) and the cut-off value (35, 40, 45, and 50 mm) were used
for the optimization to find out the maximum reduction of the dose calculation
matrix not affecting the quality of the resulting test plans.
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Figure 3.3: 3D model and exemplary CT slices of the tested clinical head and
neck case.
3.3 Results and Discussion
In fig. 3.4a the dose profile of a 15 MV (10 cm)2 photon beam in water at a
depth of z=10 cm is shown, calculated by different matrices: first by a full Dij
matrix, and further by reduced D˜ij matrices with approx. 1/3 of the original
size (r0=25 mm, sampling with dose-dependent and constant probability). Using
linear falling sampling probability for the matrix reduction, the quality of the
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results falls between the constant and the dose dependent sampling. As can be
seen from the figure, dose dependent sampling leads to the lowest noise level for
a given number of D˜ij elements. This fact was validated for different field sizes
and D˜ij sizes, not shown here. These results can be explained by the different
sampling densities and error distributions along the lateral axis (see also fig. 3.2):
for dose dependent sampling, all D˜ij values outside r0 are equal to the dose
at r = r0; the maximum error occurs at large radial distances with very small
dose contributions. At the inner part of the sampling area, beginning at r0, the
error is very small. Using a constant sampling probability, the error close to
r0 is higher; the denser sampling in the outer regions (in relation to the dose
dependent sampling) cannot compensate for this. Sampling with strictly linear
decreasing probability suffers from the fact that, for practical settings of r0 and a
fixed matrix reduction factor, the sampling probability drops to 0 before a radial
distance of 82 mm has been reached. In the following only the dose dependent
sampling will be used.
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Figure 3.4: Dose profile of a (10 cm)2 15 MV photon beam in water at a depth
z = 10 cm, calculated (a) by a full and by sampled matrices (constant and dose
dependent sampling probability) and (b) by a full, a dose dependent sampled and
a cut-off matrix.
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Fig. 3.4b again shows the dose profiles for the full and the dose-dependent
sampled matrices and compares them with the cutoff technique. The cutoff value
was set to r = 45 mm, so the cutoff matrix equals the size of the sampled
matrix. The profile resulting from the cutoff matrix is smooth, but consistently
underestimates the dose. Because it equals 0 for all points further than 45 mm
from the geometrical field border, the underestimation of the scatter cannot be
completely corrected by scaling the profile to the correct integral dose. In contrast
to that, the profile resulting from the sampled matrix shows little noise (about
3% of the maximum dose value), but by averaging over a small area the dose is
correctly predicted even in the outer regions.
Using the dose dependent probability for sampling has an additional potential
for reducing the matrix size: Because all sampled values at a fixed radiological
depth have the same value, it is no longer necessary to store every dose value sepa-
rately; instead, this value can be stored only once, together with all its associated
voxel indices. This technique is not implemented yet.
The optimization for the three different clinical cases shows that the optimal
setting for the dose-dependent sampled matrix D˜ij is r0=25 mm. With this
setting, the treatment plan is clinically equivalent to the respective plan achieved
by the fully filled matrix in all three tested cases. As criteria the dose volume
histograms and the isodoses were used. The head and neck case was the most
challenging due to the tumor size and the problematic locations of the organs at
risk; the other two cases could be optimized with even smaller sampled matrices
(i.e., D˜ij matrices with r0=20 mm) without degrading the plan. The head and
neck case is presented in detail and the results of the three different (full, sampled
and cutoff) optimization methods are compared. Again, for the cutoff technique
we used a cutoff value of 45 mm for a comparable matrix size. Table 3.1 lists
the key data for the three methods. The resulting optimization time of 45 min is
clearly not satisfactory for routine clinical use. Sampling the matrix reduces the
memory requirements and speeds up the calculation by a factor of approx. 3. The
quality of the final treatment plan is not affected, see also the DVH-comparison
in fig. 3.5a.
The maximum difference observed between the two DHVs is a dose deviation
of 2.2% of the mean dose at the 80% volume level of the spinal cord. In contrast
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Figure 3.5: Dose-volume-histograms for the head and neck case, extracted from
dose distributions optimized (a) by a fully filled and a sampled matrix and (b)
by a fully filled and a cutoff matrix.
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Full Sampled Cutoff
(ro = 25mm) (at r = 45mm)
Number of Dij elements ˜110,000,000 ˜35,000,000 ˜37,000,000
Total memory used (MB) ˜860 ˜ 380 ˜ 400
Optimization time (min) ˜ 45 ˜ 15 ˜ 15
Mean dose (Gy) in:
Target 60.0 60.0 60.0
Boost 61.9 62.0 62.3
Spinal Cord 22.5 22.4 24.0
Parotid 18.9 19.0 18.3
Brainstem 12.9 12.9 13.1
Table 3.1: Comparison of the optimizations for the head and neck case by differ-
ent dose calculation matrices. All computations were done on a Compaq Alpha
workstation 600 MHz.
to this plan, the simple cutoff approach results in a significantly degraded plan,
with a higher dose to the spinal cord. This is also shown in the DVH-comparisons,
see fig. 3.5b. Here the maximum difference, again at the 80% volume level of the
spinal cord, is 16.4%.
Figure 3.6: Transverse CT slices of the head and case. The outlines of the horse-
shoe formed target and the spinal cord are shown as black lines. The isodoses
of the dose distributions optimized (a) by a full, (b) by a sampled and (c) by a
cutoff matrix are labelled with the absolute dose values in Gy. Additionally, the
directions of the 7 beams are shown.
Fig. 3.6 shows a transverse slice through the neck region, showing the outlines
of the target and the spinal cord, together with the isodoses and the 7 beam
directions. The 30Gy isodose inside the spinal cord is almost identical for the full
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and the sampled matrix optimizations, but is located more centrally for the cutoff
matrix optimization. Because the dose level rises from inner to outer portions of
the spinal cord, this is another illustration of the higher dose deposition in this
area.
The degrading of a treatment plan optimized by a cutoff matrix is due to the
fact that the optimization algorithm cannot consider scatter contributions to an
organ at risk if the central ray of a pencil beam is further away than the cutoff
distance; so the algorithm tends to over amplify such a pencil beam to gain the
required dose in the target volume.
Because the dose distribution is given by eq. 3.1, it is clear that a dose calcu-
lation matrix Dij with 1/3 of the original size results in a three-fold speed gain
of the dose calculation. However, it has to be noted that also the number of iter-
ations determines the overall length of the optimization process. Using sampled
dose calculation matrices does not increase the number of iterations, although
there are small statistical fluctuations which could have slowed down the con-
vergence. This slow down does not occur because in the iterative update of the
fluence matrix many voxels are projected to each bixel, averaging the noise out
(see also Fig. 3.4b).
The largest deviation between the DVHs for the different techniques is ob-
served in the head and neck case. Also in the other two cases (not shown here)
the sampling leads to better or at least equivalent results compared to the cutoff
method (with no differences to full-matrix optimization in the DVHs and iso-
doses for r0 =25 mm). It should also be noted that the sampling technique shows
excellent agreement with the “exact” values for both relative and absolute dose
distributions. The cutoff approach does not calculate the absolute dose (i.e., the
output factor) well.
The following calculations shown in this thesis were performed with the op-
timal setting (r0=25 mm for a 1 cm
2 pencil beam) found in this investigation.
In future, tests on more clinical cases should be performed to ensure that this
parameter setting is always sufficient to gain an optimal treatment plan. The
results obtained so far, especially for the complicated head and neck case which
is a real challenge for every inverse planning system, indicate that this is likely
to be the case.
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Compared to measurements, the currently implemented dose calculation algo-
rithm achieves the same accuracy as the pencil beam algorithm by Bortfeld et al.
(1993), which is 2-3% for the wide majority of clinical treatment sites. In some
cases with complex tissue inhomogeneities (e.g., in the lung and the nasophar-
ynx), the error can be higher. For these cases, more sophisticated dose calculation
algorithms like superposition or Monte Carlo methods are preferable. These slow
calculations have to be performed only once to build the matrix Dij while the
following optimization loop remains unchanged. Therefore it will be more time
consuming to build the matrix (for the implemented pencil beam algorithm the
build time is about 8 min on a Alpha 600 MHz workstation), but the time needed
for the optimization process itself will not increase. The sampling technique pre-
sented in this chapter is applicable wherever the dose calculation is performed
through a precalculated matrix holding the dose contributions from every bixel
to every voxel, independently from the algorithm used for the generation of the
matrix.
Chapter 4
The equivalent uniform dose:
Models and parameters
Introduced in section 2.2, the concept of equivalent uniform dose (EUD) is a
central component of the multicriteria optimization project. Each treatment
plan is represented by a vector containing the EUD values of each structure. The
definition of Pareto optimality is based on the EUD values, and the EUD is used
in the interactive planning session to navigate through the database of treatment
plans.
This chapter presents the existing “generalized mean” EUD model and devel-
ops the new “max & mean” EUD model. Their parameters are determined by a
fit to published clinical tolerance doses, and their predictions for different treated
volume fractions are compared and discussed.
4.1 Introduction
Even with the most sophisticated radiotherapy techniques it is impossible to
deliver a perfect homogeneous dose to the target volume and no dose to healthy
normal structures around it. The dose in each structure will always have a more
or less inhomogenous distribution, given by a vector d containing the dose values
of the voxels. Those vectors are not well suited for plan optimization: If there
are two plans where one element of d is higher in the first plan and another
element of d is higher in the second plan, it is hard to decide which plan is
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better in a clinical sense. Therefore it is helpful to reduce the complex three-
dimensional dose distribution to a clinical more meaningful scalar value that
allows the ranking of different distributions. One attempt to accomplish this is
based on the ”effective dose” (Brahme 1994) or ”equivalent uniform dose” (EUD)
(Niemierko 1997, Niemierko 1999). It is defined as the homogenous dose in an
organ that has the same clinical effect as the given, arbitrary inhomogeneous dose
distribution. In organs at risk the effect of different spatial dose distributions
strongly depends on the organ type. Some organs tolerate very high dose values
in small sub-volumes, if the rest of the organ is spared. These organs have a
parallel structure: the function is preserved even if a certain fraction of the organ
is destroyed. Typical examples are the lung (Kwa et al. 1998a, Theuws et al.
1998), the parotid glands (Eisbruch et al. 1999), the kidneys and the liver. In the
other category of organs, high doses are harmful even if they are limited to small
volumes - the organ structure is serial. Typical examples for this are the spinal
cord and the bowel. The dependency of the tolerance dose on the treated volume
is called “volume effect”. For different clinical endpoints, there can be different
EUD values for the same dose distribution inside an organ, e.g. for pneumonitis
and fibrosis in the lung.
The clinical effect of tumor control in the target volume depends on the killing
of all clonogen tumor cells. Underdosage even in a small area of the target
volume might lead to the survival of some cancer cells and failure of local tumor
control. Therefore the EUD in the tumor target volume will mainly depend on
the minimum rather than the maximum dose values.
It should be noted that the concept of equivalent uniform dose does not tell
anything about the probability of a clinical effect. The EUD is still a dose, usually
given in Gray (Gy). The calculation of the tumor control probability (TCP) and
the normal tissue complication probability (NTCP) requires further biological
modelling. However, the EUD can serve as an input parameter for such models.
For NTCP models, this is equivalent to the ’DVH reduction technique’ by Kutcher
et al. (1991). Typical TCP/NTCP models have a sigmoidal shape when plotted
as a function of EUD.
There are two basic approaches for modelling equivalent uniform dose and
TCP/NTCP: the mechanistic and the phenomenological approach. The first one
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is based on biological considerations, e.g. cell kill statistics. The latter merely
tries to find analytical functions that reproduce given clinical data. The mecha-
nistic approach is inherently more satisfying, but struggles with the complexity
of biology. E.g., the mechanistic NTCP model for parallel organs by Jackson et
al. (1993) produces an unrealistic NTCP curve that is almost a step function.
Only with additional parameters identified with inter-individual heterogeneity of
functional reserves and radiosensitivities, the slope becomes shallower. Unfor-
tunately, often these parameters are unknown and cannot be determined inde-
pendently from the model. At the present time the phenomenological approach
seems to be more appropriate for practical use.
One drawback of all existing EUD models to date is that the spatial loca-
tion of the dose is not taken into account. For an organ at risk with complex
substructures it probably has a big impact on the clinical effect where exactly
a high dose area is located. Taken the heart as an example, a high dose area
in the ventricle with high blood flow should do no harm to the organ, whereas
the same dose located at one of the valves might cause complications. Future
EUD models might consider the localization of the dose values inside an organ,
e.g. by assigning weights to each voxel. At the present day the data basis, i.e.
information about 3D dose distributions and their clinical effects, is too small for
such sophisticated models. It can be expected that with the broad introduction
of 3D planning systems and computerized documentation more clinical data will
become available, and the validity of EUD and TCP/NTCP models will improve
(Trott 1996).
4.2 The generalized mean model
This section introduces the EUD model that is most widely used in radiotherapy
research. It was formulated by Niemierko (1999) in the form
EUD(d) =
(
1
N
N∑
i=1
dai
)1/a
. (4.1)
N is the number of voxels in the structure of interest, d = (d1, .., dN) the dose
distribution inside the structure, and a is an tissue-specific parameter. Originally
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Niemierko formulated the EUD for tumor volumes using a linear-quadratic cell
survival model (1997). Eq. 4.1 is valid for both tumors (without considering
fractionation) and normal tissues. While it holds its original meaning for tumors
(Niemierko 1997), it is a phenomenological model for organs at risk. It can be
derived from the power-law relationship that describes the dose-volume effect
(Lyman et al. 1987, Mohan et al. 1992, Kwa et al. 1998b):
TD(ν) = TD(1)/νn. (4.2)
Here, TD(1) is the tolerance dose if the whole organ is treated uniformly,
and TD(ν) is the tolerance dose if the fraction ν is treated and (1 − ν) gets no
dose. The magnitude of the dose-volume effect is described by the parameter n,
whereby n = 1/a.
The EUD as formulated in eq. 4.1 is the “generalized mean” of the dose
values. The mathematical properties of the generalized mean are described in
the Handbook of Mathematical Functions by Abramowitz and Stegun (1968).
Some important properties are:
• If a is negative infinity, the EUD equals the minimum dose.
• If a is 1, the EUD equals the mean dose.
• If a is positive infinity, the EUD equals the maximum dose.
• It is convex (see next chapter for details).
The influence of the parameter a on the EUD is visualized in Fig. 4.1 (taken
from Wu et al. 2002). Usually target type structures will have a large negative
tissue parameter a, so the EUD is mainly determined by the lowest dose values.
Parallel organized organs at risk like the lung have a parameter near 1 and an
EUD near the mean dose. The parameter for serial organs like the spinal cord is
large positive, so the highest dose values have the biggest impact on the EUD.
4.3 The max & mean model
In this section an even simpler approach to describe the EUD in organs at risk is
formulated (see also Thieke et al. 2002b). It is based on the work by Dale and
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Figure 4.1: The left panel shows the dose volume histogram of the dose distri-
bution in some structure of interest. On the right panel, the EUD of this dose
distribution is plotted as a function of the tissue parameter a. Taken from Wu et
al. (2002)
Olsen (1997) who reported that the normal tissue complication probabilities of
purely serial and purely parallel organs at risk correspond to the maximum dose
and the mean dose in the organ, respectively. For organs with a mixed serial and
parallel structure, Dale and Olsen (1997) suggested to use a linear combination
of the maximum and the mean dose. In the following, this is called the max &
mean approach. The organ-specific parameters for this approach are determined,
and the hypothesis is investigated and tested.
The following linear max & mean model is used to represent the EUD:
EUD = αDmax + (1− α)D. (4.3)
Dmax is the maximum and D the mean dose of the radiation delivered to the
organ. α is an organ-specific parameter ranging from 0 to 1.
The values of α and EUD were calculated by a fit to the Emami tables (Emami
et al. 1991). In that paper tolerance doses (TD) for various organs were presented
depending on the irradiated relative volume ν (whereby ν takes values of ν1 = 1/3,
ν2 = 2/3 and ν3 = 1) and on two levels of complication rate (5% and 50%, in
the following specified as TD5 and TD50) 5 years after treatment. For each
complication rate, the associated maximum and mean dose can be determined
straightforward: Because the fraction ν gets the dose TD and the fraction (1−ν)
gets no dose, the maximum dose is given as Dmax = TD and the mean dose is
given as D = ν · TD.
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From these data the organ-specific parameter α can be deduced, which should
be independent of the complication rate, and two EUD-values (EUD5 and EUD50),
applying to a complication rate of 5% and 50%, respectively. To perform the fit,
we rewrite the max & mean model as α(D − Dmax) + EUD=D and build an
overdetermined equation system for each individual organ:

(1− ν1) 1 0
(1− ν2) 1 0
(1− ν3) 1 0
(1− ν1) 0 1
(1− ν2) 0 1
(1− ν3) 0 1

·

α
EUD5
EUD50
 =

ν1 · TD5(ν1)
ν2 · TD5(ν2)
ν3 · TD5(ν3)
ν1 · TD50(ν1)
ν2 · TD50(ν2)
ν3 · TD50(ν3)

(4.4)
This can be abbreviated as A ·x = c, and a least-square fit of the three param-
eters α, EUD5 and EUD50 can be performed by calculating x = (ATA)−1AT c. As
errors the mean quadratic deviation of all meaningful quadratic subsystems (i.e.,
subsystems with 3 equations) from the least-square fit are used. ”Meaningful”
are those subsystems which lead to an exact solution for α, EUD5 and EUD50
(e.g. it is not meaningful to select the first three lines of the above equation
system because there would be no solution for EUD50).
With regard to the simple data structure provided by Emami et al. (1991),
the universal formulation of the generalized mean model,
EUD(d) =
(
1
N
N∑
i=1
dai
)1/a
, (4.5)
can be simplified to (cf. eq. 4.2, EUD=TD(1))
EUD = ν1/a · TD(ν), (4.6)
which leads to values for a and EUD in a very similar way as for the max & mean
model.
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Organ α EUD 5 [Gy] EUD 50 [Gy]
Larynx (necrosis) 0.83±0.13 68.6±4.1 78.3±4.1
Larynx (edema) 1.00 45.0
Lung I 0.09±0.09 18.7±2.4 26.0±2.9
Heart 0.53±0.12 39.7±2.9 48.2±3.0
Esophagus 0.90±0.03 55.7±0.7 67.6±0.9
Stomach 0.83±0.07 51.7±2.2 63.5±2.6
Small intestine 0.80±0.09 41.7±2.5 53.6±4.3
Colon 0.75±0.02 45.4±0.7 54.6±0.8
Liver 0.50±0.12 30.8±3.0 38.0±2.9
Kidney I 0.17±0.08 22.4±0.8 28.5±1.0
Bladder 0.64±0.19 67.7±4.5 77.4±2.6
T-M joint mandible 0.89±0.08 59.4±2.3 71.0±2.6
Brain 0.67±0.06 45.4±1.8 58.7±1.9
Brain stem 0.75±0.04 49.5±1.0
Brachial plexus 0.96±0.00 60.1±0.2 74.9±0.2
Ear mid/ext (acute) 1.00 30.0 40.0
Ear mid/ext (chronic) 1.00 55.0 65.0
Parotid I and II 1.00 32.0 46.0
Table 4.1: Fitting the max & mean model to the data by Emami et al. (1991).
4.4 Results
Table 4.1 shows the result of the fits (the particular clinical endpoints are only
noted for organs with more than one endpoint, the other ones can be found in
(Emami et al. 1991). For the larynx (endpoint edema) and the brain stem only
data for a complication rate of 5% are provided. Wherever no error is listed in
table 4.1, only two TD(ν)-values are given by Emami et al. (1991), making the
fit mathematical exact.
Once the values of α and EUD respectively a and EUD have been fitted, the
tolerance dose TD(ν) of an arbitrary irradiated fraction ν can be calculated. To
compare the generalized mean model with the max & mean model, the tolerance
dose TD(ν) is plotted as a function of the irradiated fraction ν. Fig. 4.2 show
these plots for the cases of the lung (α=0.09, a=1.18), the heart (α=0.53, a=2.94)
and the esophagus (α=0.90, a=16.67), representing different organ structures
from ”mostly parallel” to ”mostly serial”. Both models fit the data within a
tolerance of about 10%.
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Figure 4.2: Tolerance doses in dependency on the irradiated volume fraction.
Shown are the discrete values given by Emami et al. (1991) and the comparison
of the generalized mean and the max & mean EUD models. (a) Lung, (b) Heart
and (c) Esophagus.
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4.5 Discussion
The results show that the max & mean model can be fitted to the Emami tables
with the same accuracy as the standard generalized mean model. A single value of
α suffices to characterize most organs at different tolerance dose levels. Whether
the model can also be fitted to real clinical data remains to be seen when more
data become available. It has to be noted that all error ranges shown in this
chapter are the fit errors with respect to the tables by Emami et al. (1991).
The errors of the Emami data themselves, which for some organs are highly
speculative, are not considered.
Especially from figure 4.2c it is obvious that the max & mean model differs
from the generalized mean model in the case of small treated sub-volumes. Math-
ematically this is clear because the power law expression of the generalized mean
model has a pole at ν = 0, i.e. according to this model small sub-volumes can
be treated with extremely high doses. This is not the case for the max & mean
model, which is quite sensitive to small hot spots. On the one side this can be ad-
vantageous: If the model is used for plan evaluation in inverse treatment planning,
overdosages in small sub-volumes of a serial organ can be effectively reduced; in
some cases the use of the generalized mean model or quadratic deviations from
a subscribed physical dose penalize such overdosages not strong enough. On the
other hand, an organ at risk lying directly next to the tumor target volume has
to get a high dose at the border in order to achieve the curative dose in the tumor
volume. High doses in very few organ voxels should therefore be made possible.
So a reasonable way to deal with the characteristic of the max & mean model
is the appropriate determination ofDmax: It should be identified with the highest
mean dose over a certain sample volume, e.g. about 1.5 cm3, rather than the
highest dose value of one single point. This definition follows ICRU 50 (1993) and
ensures that the dose values in areas with a steep dose gradient (i.e. at the border
of organs at risk lying directly next to the target volume) are not overestimated.
Again, also for small treated sub-volumes more clinical data are desirable for
a better evaluation of the different models.
A benefit of the max & mean approach is that it can be applied to retrospective
data even if only the maximum and the mean doses are known. However, for
organs with a steep dose gradient it is important to know the exact definition of
the maximum dose.
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It remains to be investigated whether a similar approach as the max & mean
approach can also be used to characterize the minimum dose constraint in the
tumor target volume. Obviously, since here the minimum dose is more relevant
than the maximum dose, one should rather use a ”min & mean” approach.
One main advantage of the max & mean EUD concept is its linearity. It
allows the formulation of the multicriteria optimization problem in form of a
linear program. The EUD based on the max & mean model can be used in such
a program as maximum constraint for organs at risk. As minimum constraint for
the target volume, the standard minimum physical dose constraint can be used.
The linear program has the following setting:
Subject to the constraints
EUD(Dk) ≤ Uk(1 + tk), k=1, . . . ,K ”risk constraints” (4.7)
and
Min(DT) ≥ L(1-t) ”target minimum constraint”, (4.8)
independently minimize the objectives
tk → min, k=1, . . . ,K; t→ min. (4.9)
Here, the numbers Uk are ideal tolerance doses for organs at risk while L is
an ideal curative dose for the target volume. The target volume is additionally
considered as an organ at risk to ensure dose homogeneity.
The max & mean model and the generalized mean model can be fitted within a
similar error range (about 10%) to the presently available (Emami) data. At this
time, it is not clear which model describes an inhomogenous dose distribution
with a higher clinical relevance. Therefore it seems appropriate to implement
both models into the multicriteria optimization project.
The linear max & mean model has good numerical properties and can be
solved in standard linear programming tools that are commercially available. The
collaboration partners of the multicriteria optimization project at the Fraunhofer
Institute for Industrial Mathematics are working on the generation of Pareto
optimal solutions using the max & mean model and linear solver tools.
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Because of the power-law formula, the generalized mean EUD model is in
general not linear. Commercially available linear solvers cannot be used for op-
timizing plans using this EUD model. In the next chapter a new algorithm that
solves this problem is developed and tested.
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Chapter 5
The equivalent uniform dose as
an optimization constraint
Optimization algorithms in inverse radiotherapy planning need information about
the desired dose distribution. Usually the planner defines physical dose con-
straints for each structure of the treatment plan, either in form of minimum and
maximum doses or as dose-volume constraints. In the multicriteria optimiza-
tion project the equivalent uniform dose (EUD) was chosen as criterion for each
structure in the treatment plan. In consequence it should be the EUD instead
of physical dose that is used as an optimization constraint in the calculation of
treatment plans.
In this chapter, a method is presented to consider the generalized mean
EUD model as an optimization constraint by using projections onto convex sets
(POCS). The actual dose distribution is repeatedly projected onto the set of dis-
tributions that fulfil the EUD constraint, leading to voxel-based physical dose
constraints. The algorithm is easy to integrate into the existing inverse plan-
ning systems. It can also be used in existing (weighted and constrained) inverse
optimization setups as well and not exclusively in multicriteria optimization. It
is possible to choose between physical and EUD constraints separately for each
structure, allowing the planner to make use of the EUD concept in conventional
inverse planning and carefully test this new concept in radiotherapy optimization.
The following sections (see also Thieke et al. 2002c) are therefore valid for
both the existing inverse planning concepts and the multicriteria optimization
project.
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5.1 Introduction
In current inverse treatment planning programs for intensity-modulated radio-
therapy, the planner defines certain constraints for the desired dose distribution,
and in an optimization process the computer tries to find the treatment setup that
matches the constraints as closely as possible. Common constraints for the opti-
mization are minimum and maximum doses for target structures and maximum
doses for normal structures, each in conjunction with a penalty factor (Bortfeld
et al. 1999).
These physical dose constraints allow the implementation of fast converging
and robust gradient optimization algorithms. However, finding the best parame-
ter setting is non-intuitive. Because often the dose constraints cannot be fulfilled
for every single voxel, the penalty factors have a great impact on the optimization
result. In these cases, the prescribed maximum dose loses its original meaning of
a real constraint and is used as a mere steering parameter for the optimization
outcome. Balancing the maximum/minimum constraints and their penalties is a
trial and error process with several optimization runs.
For some organs at risk, a pure maximum dose constraint is not meaningful
at all. As presented in the previous chapter, parallel organs like liver, lung and
kidneys show a distinct volume effect, i.e. the tolerance dose for small irradiated
volume fractions is much higher compared to irradiation of large fractions. To
consider volume effects in a physical dose constrained optimization, the planner
can define dose volume histogram (DVH) constraints, i.e. instead of a maximum
dose, the constraints are formulated in the form ”not more than x % of the
organ are allowed to receive more than y Gy”, see e.g. Bortfeld et al. 1997.
Usually several DVH constraints have to be defined for one organ. This increases
the number of parameters to be defined by the treatment planner, and it may
exclude solutions that keep organs at risk inside the tolerance, but that have a
different shape of the DVH.
The concept of EUD is probably of higher clinical relevance than single physi-
cal dose values and is therefore a promising concept for overcoming the difficulties
of physical dose constrained optimization. Wu et al. (2002) used the generalized
mean based EUD for inverse treatment planning as a parameter in a sigmoid
dose-effect curve that resembles the basic shape of TCP/NTCP models.
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In this chapter, the generalized mean based EUD is directly implemented as
an optimization constraint without assuming any dose-effect-relationships. In
the following, the mathematical aspects of the implementation are described, the
differences between physical dose constrained and EUD constrained optimization
are shown, and the clinical application is discussed.
5.2 Material and Methods
The calculation platform for the investigation is the same as in chapter 2. As an
initial step prior to the optimization loop, the dose contribution of every beam
element (bixel) j to every voxel i is stored for unit fluence in a matrix Dij. For
arbitrary beam weights w = (w1, .., wM) the dose dT = (d1, .., dNT ) can then be
calculated through
di =
M∑
j=1
Dijwj i = 1, .., NT . (5.1)
M is the number of bixels, and NT the total number of voxels.
The planning system uses a Quasi-Newton gradient technique to optimize the
fluence maps. The objective function is defined as
F =
NT∑
i=1
si
(
di − dpresi
)2
. (5.2)
d
pres
i and si are the desired dose for the voxel i and the associated penalty
factor, based on the planner’s prescription and the current dose. For minimum
and maximum dose constraints, d
pres
i and si are given by
(
d
pres
i , si
)
=

(
dmini , s
min
i
)
if di < d
min
i
(di, 0) if d
min
i ≤ di ≤ dmaxi
(dmaxi , s
max
i ) if di > d
max
i
(5.3)
(
dmini , s
min
i
)
and (dmaxi , s
max
i ) are the minimum and maximum physical dose
constraints and penalty factors for voxel i. Note that the system internally works
with individual settings for each voxel. The planner usually defines the dose
constraints and penalties only separately for each structure (targets/organs at
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risk), which are then assigned to all voxels belonging to the particular structure.
Naturally, for organs at risk the minimum dose constraint is set to 0.
DVH constraints are considered by an extension of the above concept, whereby
up to 5 DVH constraint points per structure are transformed into adequately
chosen values of d
pres
i (Bortfeld et al. 1997).
The iterative update of the beam weights from iteration (t) to iteration (t+1)
is given by
w
(t+1)
j =
[
w
(t)
j − α
(
dF
dwj
/
d2F
dw2j
)]
+
=
w(t)j − α
∑N
i=1 2si
(
di − dpresi
)
Dij∑N
i=1 2siD
2
ij

+
(5.4)
α is a damping dactor to ensure convergence, and because the fluence has to
be non-negative, the operator
[x]+ =
 x if x ≥ 00 if x < 0 (5.5)
is used.
The handling of physical dose constraints is also illustrated in Fig. 5.1.
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Figure 5.1: Illustration of maximum and DVH constraints in inverse planning.
Shown is the actual dose at some point during the optimization in an organ at
risk in form of a dose-volume-histogram. Both the maximum dose constraint
and the DVH constraint for this organ are violated in this example, and so the
optimization algorithm tries to find the dose distribution whose DVH avoids the
hatched areas. All other parts of the organ dose can remain unchanged.
It shows the DVH of a dose distribution in an organ at risk at some arbitrary
point of the optimization. One DVH constraint and a maximum physical dose
constraint are defined for this organ, and both are violated by the actual dose
distribution. The planning system then generates the arrays dpres and spres in
a way that only those voxels violating the constraints contribute to the objective
function. For all other voxels the new prescribed dose equals the actual dose.
The actual dose distribution is modified as little as possible, but also as much as
necessary to match all constraints.
This concept has proven to result in a fast and stable optimization. It was
the motivation to implement EUD constraints into the system in a way that is
compatible with the existing concept and that keeps most parts of the established
algorithm unchanged.
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The generalized mean EUD model as introduced in chapter 4 (cf. eq. 4.1) is
defined as
EUD(d) =
(
1
N
N∑
i=1
dai
)1/a
. (5.6)
Because the EUD is calculated separately for each structure, in the following
the dose vector d is restricted to those voxels belonging to the particular structure
and has N elements, d = (d1, .., dN).
Let us now assume that at any stage during the optimization we have a dose
distribution d inside the organ that violates a predefined EUD constraint, e.g.
EUD (d) > EUDmax for an organ at risk. In analogy to the handling of physical
dose constraints described above, we now want to find a new dose distribution
d′ that fulfils the constraint, i.e. EUD (d′) ≤ EUDmax, and at the same time
is as close to d as possible. The elements of d′, (d′1, .., d
′
N), can then be used as
physical dose constraints in the array dpres, see eq. (5.2).
To find d′, we make use of a mathematical property of the EUD formula, its
convexity for a < 0 and a ≥ 1 (Choi 2002). Convexity means that for two given
dose distributions within the constraint, any convex combination of these two is
also within the constraint:
αEUD (d1) + (1− α)EUD (d2) ≤ EUDmax (5.7)
for EUD (d1) ,EUD (d2) ≤ EUDmax, 0 ≤ α ≤ 1, a ≥ 1 (5.8)
and
αEUD (d1) + (1− α)EUD (d2) ≥ EUDmin (5.9)
for EUD (d1) ,EUD (d2) ≥ EUDmin, 0 ≤ α ≤ 1, a < 0. (5.10)
In other words, all dose distributions that satisfy a given EUD constraint form
a convex set inside the N -dimensional dose space. This property is essential to
make the projection from d to d′ unique. It is called a projection onto a convex
set (POCS) (Bregman 1965, Gubin et al. 1967), a technique known from other
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applications, e.g. in image restoration (Youla et al. 1982). POCS has also already
been used in radiotherapy planning (Lee et al. 1997), especially as an alternative
method for considering DVH constraints (Cho et al. 1998). Fig. 5.2 illustrates
the principle.
Figure 5.2: The principle of Projection onto convex sets (POCS).
For reasons of clarity, an organ with only two voxels (N = 2) is shown, so that
every dose distribution d = (d1, d2) can be represented by a point on the plane.
We look at an organ at risk with an EUD parameter of a = 2 and a prescribed
maximum constraint EUDpres. All dose distributions fulfilling the constraint
form a convex set that includes d = (0, 0) and has a border forming a circle
segment from d = (
√
2 · EUDpres, 0) to d = (0,√2 · EUDpres). For other organ
parameters a, the border would have a different shape, but would be still convex.
Also shown in Fig. 5.2 is a dose distribution d that violates the constraint (and
is therefore outside the convex set) and its projection to the nearest distribution
d′ of the convex set. It is clear that d′ will fulfill the EUD constraint exactly and
does not go beyond that, i.e. we will have EUD (d′) = EUDpres instead of the
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inequality used so far. The same applies for minimum EUD constraints, so the
following calculation is valid for both maximum and minimum constraints.
To calculate d′, we have to find the minimum of
f (d′) =
N∑
i=1
(di − d′i)2 (5.11)
under the constraint EUD (d′) = EUDpres. This is a classical setup for the
use of Lagrange multipliers. We define a Lagrange function
L (d′) = f (d′) + λ
(
EUDpres − EUD (d′)
)
(5.12)
and set the gradient to zero:
(
∂L
∂d′
)
j
= −2
(
dj − d′j
)
− 1
N
λd′a−1j
(
1
N
N∑
i=1
d′ai
) 1
a
−1
= 0 (5.13)
⇒ dj − d
′
j
d′a−1j
= − λ
2N
(
1
N
N∑
i=1
d′ai
) 1
a
−1
j = 1, .., N (5.14)
The explicit value of the Lagrange multiplier λ is unknown, but it can be seen
from eq. (5.14) that for every voxel index j there is a constant expression for d′j:
dj − d′j
d′a−1j
= const j = 1, .., N. (5.15)
The value of const that is exact for a = 1 and a = 2 and approximately correct
for all other values of a is given by
dj − d′j
d′a−1j
≈ EUD (d)− EUD
pres(
EUDpres
)(a−1) . (5.16)
Eq. (5.16) is an implicit definition for d′. In practice, this is as good as an
explicit definition, because each element d′j can be calculated in a short and fast
iterative sub-calculation. It is interesting to note that for a = 1 the dose is just
shifted by const = (EUD (d)− EUDpres), and for a = 2 the relative change of
the dose is constant.
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When projecting to a lower EUD, for every j it is
d′j ≤ dj j = 1, .., N, (5.17)
and when projecting to a higher EUD, used for target structures in case the
minimal EUD constraint is violated, we have
d′j ≥ dj j = 1, .., N. (5.18)
If only a minimum EUD constraint is used for target structures, eq. (5.18)
would lead to very high doses in some target voxels because they would never
be actively reduced. To assure target dose homogenity, we therefore consider
the target also as an organ at risk and prescribe a maximum EUD. There has
to be a separate target parameter a ≥ 1 for the maximum EUD constraint to
ensure the convexity. The use of both minimum and maximum EUD constraints
for target structures implies that there might be two projections directly after
one another to obtain d′: First, to a higher EUD in case the minimum EUD
constraint is violated, and starting from this dose distribution a projection down
to the maximum constraint.
In summary, the EUD constraint defined by the planner is internally trans-
formed into physical dose constraints individual for each voxel. In practice, this
is a simple replacement of eq. (5.3) by eq. (5.16). The objective function, its
gradients and all other parts of the optimization algorithm can be retained with-
out change. It is even possible to use EUD constraints only for some organs and
physical dose constraints for the others. This is illustrated in the flowchart in
Fig. 5.3. The well-established optimization program could be retained without
change, and the feature of EUD-constrained optimization is just a “plug-in” (the
part of the figure with a dotted background) into the routine that builds the array
dpres. From Fig. 5.3 one can also see how mixing of different constraint types
is implemented: Because the array dpres is calculated in a sub-loop organ by
organ, the planner can define separately for each organ either physical max/min,
DVH or EUD constraints.
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Figure 5.3: Optimization loop of the inverse planning program used for this paper.
In each iteration, a dose distribution dpres is generated, based on the current dose
and individual for each voxel. dpres is generated by processing organ after organ,
and so it is possible to chose different constraint types separately for each of them.
Because the POCS method leads to voxel-based physical dose constraints, EUD
constraints could be implemented by simply adding a branch to the generation
of dpres (marked by the dotted background in the figure).
5.3 Results
First, we will look at projections for organs at risk that violate a maximum EUD
constraint. As it can be seen from eq. (5.16), the projection from the current dose
distribution to the one that satisfies the EUD constraint depends on the tissue
parameter a. For serial organs, the EUD is mostly determined by the highest
voxel doses, so it would have little effect to change the parts of the organ that
already receive a low dose. In more parallel organs, the EUD is nearer the mean
dose, and the voxels are affected more evenly by the projection.
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Figure 5.4: Examples of projections to a lower EUD for different organ parameters
’a’. For a=1.0 (parallel organ), the DVH is shifted to the left. For a=2.0, the
DVH is scaled along the dose axis, and for a=7.4 (the parameter for the spinal
cord), higher doses are even more effected and lower dose parts are not changed
at all. The extreme case a=∞ means the equivalence of EUD and physical dose
maximum and would lead to a projection shown in fig. 5.1.
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Fig. 5.4 shows the DVHs of an arbitrary dose distribution in an organ at
risk at some point during the optimization, and its projections assuming three
different parameters a. The EUD constraint for this organ was set to 33 Gy.
Depending on a, the EUD of the current dose distribution is 50.8 Gy (a = 7.4,
which is the parameter for the spinal cord, a mostly serial organized structure),
45.4 Gy (a = 2.0) and 40.9 Gy (a = 1.0, representing a purely parallel organized
organ). For all three parameters the constraint of 33 Gy was violated, and for
each parameter the algorithm has to project to a new dose distribution. The
resulting projections are also shown in Fig. 5.4 and have an EUD of 32.4 Gy
(a = 7.4), 32.9 Gy (a = 2.0) and 34.0 Gy (a = 1.0). One can see that for a = 7.4
and a = 2.0 the EUD of the projected dose distribution meets the constraint
and is very close to it. Only for a = 1.0, the EUD of the projection is slightly
higher than the constraint. This is because the dose has to be non-negative,
and therefore shifting the dose is not completely possible in voxels with a dose
di < (EUD(d)−EUDpres). But this effect is small and becomes even smaller after
each iteration when the constraint is reached more closely, and can be neglected.
As stated in the previous chapter, for targets the situation is slightly more
complicated because there are both minimum and maximum constraints. Two
parameters are required, a negative a− for the minimum EUD constraint and
a positive a+ for the maximum EUD constraint. It is possible that the current
dose inside the target violates both constraints, or that the maximum constraint is
violated after the projection to the minimum EUD. In these cases two projections
directly after one another are necessary. Fig. 5.5 shows an exampe for a target
volume with the constraints EUDmin = 60 Gy (a− = −8) and EUDmax = 61 Gy
(a+ = 10). First, the minimum EUD constraint is reached by the first projection.
Then, the second projection ensures that also the maximum EUD constraint is
met.
In the following, we look at optimization results for a clinical case using the
common physical constraints and the new EUD constraints. The case we looked
at was an extensive head and neck tumor with a complex shaped target volume,
including a boost volume, and located very close to organs at risk: brainstem,
spinal cord and parotid gland (the same as in chapter 3, cf. fig. 3.3). Table 5.1
shows parameter settings and optimization results. Treatment plan A was calcu-
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Figure 5.5: For target structures, there is a minimum EUD constraint (associated
with a negative parameter ’a’) and, to ensure homogeneity, also a maximum
EUD constraint (associated with a positive parameter ’a’). This can lead to two
projections in one iteration to find a prescribed dose distribution that fulfills
both constraints. In this example the constraints were set to EUDmin=60Gy
and EUDmax=61Gy.
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Plan A
(physical)
Plan B
(physical/EUD)
Plan C
(EUD)
Optimization
constraints (Gy):
Target (a-=-8)
(a+=10)
Dmin=60
Dmax=60
Dmin=60
Dmax=60
EUDmin=60
EUDmax=61
Boost (a-=-8)
(a+=10)
Dmin=62
Dmax=62
Dmin=62
Dmax=62
EUDmin=62
EUDmax=63
Spinal cord (a=7.4)
Brainstem (a=4.6)
Parotid gland (a=1)
Dmax=33
Dmax=45
Dmax=25
EUDmax=25.5
EUDmax=23
EUDmax=13
EUDmax=25.5
EUDmax=23
EUDmax=13
Result EUD (Gy):
Target (a-=-8)
(a+=10)
58.5
60.2
58.5
60.5
58.5
60.7
Boost (a-=-8)
(a+=10)
61.8
62.0
62.1
62.3
61.6
62.7
Spinal cord (a=7.4)
Brainstem (a=4.6)
Parotid gland (a=1)
28.8
27.7
17.6
25.8
23.1
13.5
25.4
22.9
13.0
Iterations 216 309 500
Table 5.1: Optimization constraints and results for the head and neck case. For
plan A, only physical constraints were used, for plan B physical constraints for
the target/boost volumes and EUD constraints for the organs at risk were used,
and plan C was optimized using EUD constraints for all structures. All plans
were normalized to a target EUD of 58.5 Gy.
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lated with maximum and minimum physical dose constraints for all structures.
In treatment plan B the organs at risk were optimized using EUD constraints
while keeping the physical constraints for the target, and plan C is the optimiza-
tion result using EUD constraints for both organs at risk and the target. The
slightly more elaborate generation of the prescribed dose array dpres for EUD
constraints (compare eqs. (5.3) and (5.16)) is not noticable in terms of compu-
tation time: The time needed for one single iteration is the same for physical
and for EUD constraints; in this specific case this is approx. 7 sec on a Pentium
IV 1.4 GHz workstation. But the total number of iterations needed increases for
EUD constrained optimization, cf. Table 5.1. Fig. 5.6 shows both the DVHs of
plan A and plan B. The EUD values of all structures in plan A and the target
EUDs in plan B are displayed only for informational purposes; they were not used
during the optimization. Plan B with EUD constraints shows better sparing of
the organs at risk while keeping the dose in the target at the same level as plan
A. For the parotid gland (a parallel organ with a = 1), in plan B the maximum
dose values are higher, but the mean dose (and therefore the EUD) is lower. For
all structures, the EUD constraints are reached very closely. In Fig. 5.7, the
DVHs of plan C and, again, plan B is shown. The results are similar, but the
homogeneity of the target, especially the boost, in plan C is worse than in plan
B.
5.4 Discussion
As can be seen in the results section, the algorithm presented is capable of find-
ing a plan that reaches given EUD constraints closely. It needs more iterations
than the physical constrained optimization, but using EUD constraints only for
organs at risk, the convergence is still good. Although in the test case the EUD
constrained optimization shows better sparing of organs at risk than the physical
constrained optimization, this cannot be claimed in general. The results depend
directly on the concrete constraint settings. It is also important to note that
the EUD of an organ at risk is not optimized beyond the constraint. Without
further modifications to the algorithm (which are presented in section 6.2.1), the
planner has to define a sufficiently low constraint to minimize the EUD as much
as possible.
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Figure 5.6: Optimization results for the head and neck case. Plan A was generated
using physical maximum/minimum constraints for all structures. For plan B the
target and boost constraints were the same as in plan A, but the organs at risk
were optimized using maximum EUD constraints.
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Figure 5.7: Again optimization results for the head and neck case. Plan B is the
same as in figure 5.6, now compared to a plan C where EUD constraints were
used for all structures.
60 CHAPTER 5. THE EUD AS OPTIMIZATION CONSTRAINT
The same optimization result as in plan B could have been also reached with
a set of DVH constraints. However, these DVH constraints were unknown, and
finding the best set would require a lot of trial and error (Wu et al. 2002). The
fact that EUD constraints can lead to a better overall result in the organs at risk
than simple maximum dose constraints becomes plausible by looking at Fig. 5.1
and Fig. 5.4: Whereas no voxel below the maximum dose constraint is optimized
(see Fig. 5.1), the EUD constraint affects, depending on the organ parameter,
much more or even all voxels of the organ (see Fig. 5.4).
The question is where the use of EUD constraints is most suitable and how
they compare to the physical constraints. From eq. (5.6) one can see that when a
is positive infinity (completely serial organized organ), the EUD equals the maxi-
mum dose in the structure. In this case, the POCS method projects exactly onto
the maximum dose constraint, so the use of “maximum physical dose constraint”
and “maximum EUD constraint” is equivalent. In analogy, a set to negative
infinity (where the EUD equals the minimum dose) implies the equivalence of
a minimum EUD constraint and a pure physical dose minimum constraint. In
that sense the pure physical maximum/minimum dose constraints are a subset of
EUD constraints, namely for structures with a set to +/-∞.
The differences become bigger and bigger when the organ structure becomes
more and more parallel (cf. parotid gland in Fig. 5.6), indicating that a physical
maximum dose constraint is no longer sufficient. Especially for these organs, ei-
ther DVH constraints or EUD constraints should be used. The EUD constraint
is easier to define and does not imply a predefined shape of the DVH. The opti-
mization will find the dose distribution that is best adapted to the specific case.
As found in the results section, even for organs considered as mostly serial (like
the spinal cord) EUD constraints can improve the optimization result.
EUD constraints for target structures using organ parameters as in plan C
resulted in more iterations and lower dose homogeneity. So for targets the use
of higher a+ (for the max. EUD constraint) and lower a− (for the min. EUD
constraint) organ parameters up to positive/negative infinity seems more suitable.
The algorithm presented makes it possible to integrate the non-linear gener-
alized mean EUD model into the multicriteria optimization concept. This will be
utilized in the next chapter where a complete set of Pareto optimal solutions is
generated and stored in a database.
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In addition to the implementation in multicriteria optimization, another main
advantage of the algorithm presented is that it can be used in the common inverse
planning concepts. It is very close to the existing physical optimization and is easy
to integrate into any inverse planning system that uses a gradient optimization
technique and voxel based dose constraints. Virtually nothing of the existing
system has to be changed; the EUD constraint is just an additional feature and
is realized by a simple plug-in, cf. Fig. 5.3. For every organ or structure the
planner can decide separately what kind of constraint should be used. It is not
necessary to change the whole planning paradigm. Inverse planning is a process
that requires a lot of experience from the planner, and the introduction of EUD
constraints as presented does not render this experience obsolete. Instead, it is
possible to make use of the EUD concept in a conservative way by using an EUD
constraint only for selected organs, and use physical dose constraints and the
knowledge about the correct settings for constraints and penalty factors for all
other organs. This ensures a smooth transition from a pure physical dose oriented
to a clinical more meaningful optimization. When more and more clinical data
become available and the parameters for tissue parameters and tolerance doses
become more valid, the planner can make use of it by using the EUD feature
for more organs. The usefulness of a smooth transition is also supported by the
fact that planning based on TCP/NTCP models was introduced several years
ago (Sodertrom et al. 1993, Niemierko et al. 1992) but is still not widely used
in clinical practice. The EUD is an intermediate concept between physical doses
and TCP/NTCP models. It is still in the dose domain and does not cope with,
but on the other hand is also not affected by the uncertainties of dose-effect
relationships.
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Chapter 6
Practical application of
multicriteria optimization in
inverse radiotherapy planning
The fundamental algorithms and analyses described in the previous chapters now
allow the practical application of multicriteria optimization. This chapter de-
scribes the first implementation of a multicriteria optimization scheme in inverse
intensity-modulated radiotherapy planning. After presenting a simple clinical
test case, some techniques that might become important for more complex cases
are introduced as well.
6.1 Clinical test case with 1 target volume and
2 organs at risk
6.1.1 Introduction
The most simple anatomic situation for radiotherapy optimization is one single
target volume next to one single organ at risk. However, for such a case there
exist also only one single Pareto optimal solution (assumed that there is only one
criterion representing the target dose distribution). Different doses to the target
volume can be achieved by scaling the whole plan to different dose levels.
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So, the clinical case investigated here is a case with one single target volume
and two organs at risk. The three structures are configured in a way that for a
given target dose both organs at risk unevitably get some dose as well. Sparing
one organ at risk at risk might lead to a higher dose to the other, i.e. there are
many Pareto optimal plans with different compromises for the two risks. The
questions are:
1. What are the Pareto optimal plans?
2. How sensitive are these plans to variations of the criteria? E.g. where is
the point at which one organ cannot be improved without heavily worsen
the other?
6.1.2 Material and Methods
The clinical case used for this study was the head and neck case introduced in
chapter 3 and 5. To reduce the complexity of the problem, the brainstem and
the boost were taken out of the optimization. Those structures have turned out
to be uncritical and not dose limiting. The remaining structures are the target
volume (now including the volume of the former boost), the parotid gland and
the spinal cord.
In this first incarnation, a simple “brute force” strategy for generating the
database of Pareto optimal plans is implemented. Following settings are used:
• The dose prescription for the target volume is set to minimum dose =
maximum dose = 60 Gy.
• For the organs at risk, EUD constraints are used. The EUD maximum
constraint is varied from 0 to 30 Gy in steps of 2 Gy for both parotid
gland and spinal cord. All combinations of constraints are fully optimized,
resulting in 16x16=256 plans.
• Each plan is normalized to a target EUD(a− = −8) of 60.0 Gy. To ensure
a certain homogeneity of the target dose distribution, a plan is rejected if
the target EUD belonging to a+ = 10 is higher than 67.0 Gy.
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• If the plan is accepted, it is added to the database. The EUD values, the
intensity matrices, and an optimization summary is saved to the harddisk.
After normalizing the plans and filtering out the plans with too inhomogeneous
target dose, the dose to the target in all remaining plans can be considered as
equivalent. This allows the graphical representation of the plan database by
plotting the EUD values of parotid gland and spinal cord on a two-dimensional
plane.
6.1.3 Results and Discussion
The total calculation time was 17 hrs for the 256 plans (approx. 4 min per plan)
on a Pentium IV 1.8 GHz workstation. 88 of these plans were rejected because
of the homogeneity criterion. The remaining 168 plans can be divided into the
subgroups “Pareto optimal” and “dominated”. A Pareto optimal plan can easily
be identified by the fact that there exists no other plan with a lower EUD in one
organ at risk without a higher EUD in the other organ at risk. It turned out that
the database contains 19 Pareto optimal and (168-19)=149 dominated plans.
Figure 6.1 shows the database of plans graphically by plotting the EUD of the
parotid gland in dependency on the EUD of the spinal cord. The Pareto optimal
plans mark the border between the physically feasible area to the non-feasible
area. The planner is only interested in the Pareto optimal plans, the dominated
plans are shown only for informational purposes. A final database contains only
the Pareto optimal subgroup.
The graphical representation gives detailed information about the concrete
planning situation very quickly. E.g., at first sight the planner realize that it is
physically impossible to achieve an EUD of 5 Gy in both spinal cord and parotid
gland (unless the target dose is scaled below 60 Gy EUD). It also becomes clear
at first sight up to which point the EUD in one organ at risk can be improved
without significantly worsening the dose in the other. In this case, most probably
a treatment planner would decide between the plans marked with A, B and C.
The DVHs of these plans are shown in Fig. 6.2.
The decision which plan will finally be used for treatment is up to the planner
and can be based on clinical considerations. If all of these plans would lead to
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Figure 6.1: Database of all plans that satisfy the target dose EUD and homo-
geneity constraints. Each plan can therefore be represented by its EUD values
for parotid gland and spinal cord. Only the Pareto optimal plans are of interest
for the treatment planner.
CHAPTER 6. APPLICATION OF MULTICRITERIA OPTIMIZATION 67
Figure 6.2: DVHs of Plan A, B and C.
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inacceptable high risks of radiation damage, the dose to the target volume has to
be reduced. By scaling the whole database, all plans will remain Pareto optimal
and the planner can be sure to stay at the physical optimum.
In the future, the algorithm might detect the most interesting part of the
database automatically (in this case, the part around plans A, B and C) and
produce additional Pareto optimal plans to allow finer plan tuning (see also the
subsection “Plan interpolation” below).
In this simple example, the target dose was at a fixed level of EUD value and
dose homogeneity. However, it would be of clinical interest to consider target
type structures with two criteria: First, the dose level in terms of EUD regarding
a parameter a−, and a second criterion measuring the dose homogeneity (e.g. the
EUD regarding a high positive parameter a+). The dose homogeneity can then
be included into the multicriteria decision process as an additional parameter just
like the EUD in an organ at risk. This way no plan has to be rejected, and in
that sense a case with one target volume and one volume at risk as described in
the introduction would already have three criteria. In fact, in clinical practice it
is a frequent situation that the balance between the target dose homogeneity and
the dose to one organ at risk is the most difficult problem.
As soon as there are more than two criteria to consider, the database cannot
be represented by a simple two-dimensional plot. In this case the more elaborate
search tool from ITWM Kaiserslautern presented in chapter 2 has to be used.
However, to get an overview for the dependency of one structure on another
it might still be useful to lock all other criteria and have a look at the two-
dimensional plot of the remaining two structures.
6.2 Techniques for more complex cases
It is clear that the crude method used for the clinical test case in the previous sec-
tion is not sufficient for the multicriterial optimization of cases with more organs
at risk and probably several target volumes. If all combinations of constraints are
fully optimized, the number of necessary optimization runs would increase expo-
nentially, taking by far too much calculation time. Therefore more sophisticated
methods have to be implemented to keep the calculation time within clinically
acceptable limits.
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One method could be to restrict the multicriteria optimization to those struc-
tures of the treatment plan that are the crucial, dose-limiting elements. Usually,
in treatment plans with many structures there are some organs at risk that are
easy to keep within tolerance, and these structures can be excluded from the
multicriteria optimization process. One example is the brain stem of the head
and neck case shown in the previous chapters. Geometric considerations and test
optimization runs could be helpful for detecting and excluding those uncritical
structures. The complete generation of the Pareto optimal plan database should
not take longer than one day, even when, say, six different criteria have to be con-
sidered. In addition to the parameter reduction, in the following two techniques
are introduced that let this goal appear realistic to achieve. These techniques are
not analyzed in full depth, nor are they already integrated into the optimization
process. The following should be understood as suggestions for the future work
on this project.
6.2.1 Adaptive constraints
As can be seen from Fig. 6.1, most of the plans that are generated by the “brute
force” method are not Pareto optimal. The time needed for the generation of
a dominated plan is wasted and could be saved if every single optimization run
already ensures a Pareto optimal result. A first test suggests that this can be
achieved by the technique of adaptive constraints. Adaptive means that the con-
straints are not constant throughout the whole optimization run. If the algorithm
detects that at some point of the optimization a constraint is reached within a
very close interval, it lowers the constraints automatically and continues to im-
prove the specific criterion beyond the original constraint. This has to be done
with a lowered penalty factor to avoid unwanted violation of one of the other
constraints.
Figure 6.3 shows a first result of the adaptive constraints technique. The
first plan (non-adaptive) was optimized without adaptive constraints, so the op-
timization stopped as soon as the prescribed EUD constraints were reached. The
second plan (adaptive) was optimized beyond these constraints, so with the same
starting EUD constraints a better optimization result in brainstem and spinal
cord could be achieved. The dose to the parotid gland could not be improved
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Figure 6.3: Adaptive constraints.
beyond the prescription, indicating that the dose to this organ was already as low
as possible.
6.2.2 Plan interpolation
A second technique to further reduce calculation time also avoids unnecessary
optimization runs. It is motivated by the fact that between two Pareto solutions
a third solution can be approximated by linear interpolation. Because in the
dose calculation engine the dose depends linearily on the intensities (eq. 3.1),
both the dose distribution and the intensity matrices can be interpolated without
a new dose calculation. The interpolated plan will lie in the area of feasible
solutions. The EUD values have to be recalculated because except for perfect
parallel organized organs the EUD does not depend linearily on the dose values.
However, the linear interpolated EUD value already gives an upper limit for
the exact EUD value. Therefore in Fig. 6.1 all Pareto optimal plans could be
connected by lines; these lines give the upper EUD limits of interpolated Pareto
solutions.
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Figure 6.4: Interpolation of plans.
The question is how near the interpolated solution will be located to the
Pareto front, see Fig. 6.4.
This might be answered by adding the technique of adaptive constraints to
the interpolation: Starting from the interpolated plan, additional optimization
iterations will shift the plan to the Pareto front. One can expect that many
iterations can be saved compared to a new optimization run starting from zero.
Plan interpolation can also be useful during the interactive planning session.
If the planner cannot decide between two certain plans, plan interpolation can be
a tool to produce and present finer resolved plan alternatives on-the-fly.
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Chapter 7
Summary and Outlook
Multicriteria optimization in inverse radiotherapy planning is a collaborative re-
search project of the German Cancer Research Center (DKFZ), the Fraunhofer
Institute for Industrial Mathematics (ITWM) and the Massachusetts General
Hospital (MGH). This thesis dealt with some fundamental techniques and ques-
tions associated with the multicriterial approach. Because of the high number of
optimization runs, the optimization had to be accelerated. This could be achieved
through sampling of the dose calculation matrices. The next question was about
which criterion should be used to represent each structure in the multidimen-
sional plan description vector. Two models of the equivalent uniform dose were
analyzed and compared. It turned out that the new linear max & mean model
is a promising alternative to the established generalized mean model. While
the optimization with the max & mean EUD is investigated by the collaboration
colleagues at ITWM, a new optimization algorithm had to be developed to imple-
ment the generalized mean EUD as an optimization constraint. This problem was
solved by using the method of projection onto convex sets. Finally, all techniques
were utilized to produce a database of Pareto optimal plans of a simple clinical
test case. It gives a first impression of the new quality of treatment planning
that multicriteria optimization is capable to deliver. Some advanced techniques
for more complex cases, namely adaptive constraints and plan interpolation, are
briefly introduced as well.
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It should be noted that some of the presented material is useful for existing
inverse planning systems even outside of multicriteria optimization schemes. The
new inverse planning system at DKFZ makes use of the accelerated dose cal-
culation and is faster in all modes of photon treatment optimization. Also the
generalized mean EUD constraints can be used for inverse planning in general.
The possibility to mix EUD with physical dose constraints is especially useful to
smoothly introduce this new concept to existing systems.
This thesis can be considered as a first milestone of the multicriteria optimiza-
tion project. While fundamental techniques and algorithms could be realized,
further work has to be done to fully exploit the possibilities of the multicriteria
optimization concept. For example, the techniques presented in chapter 6 have
to be included into the optimization engine in order to produce Pareto optimal
plan databases for complex cases. Another investigation will have to deal with
the question of the planning horizon, i.e. up to which dose and in what resolution
plans have to be generated and included into the database. Maybe the integration
of TCP/NTCP models will be useful in this context. Upcoming clinical data will
further improve the reliability of both the TCP/NTCP and the EUD concept.
In conclusion, the multicriteria optimization concept provides the basis for
powerful tools that assists the radiotherapy planner in achieving the ultimate
goal: finding the treatment plan that is the best for the patient.
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